Related Experiment Video
Updated: Jul 14, 2026
08:43
Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
Published on: November 30, 2012
Targeted therapy and blood-brain barrier
Agnieszka Korfel1, Eckhard Thiel
1Medizinische Klinik III, Hämatologie, Onkologie und Transfusionsmedizin, Charité Universitätsmedizin Berlin, Germany.
Summary
Targeted therapy shows promise for brain tumors due to molecular targets. However, the blood-brain barrier poses challenges for effective treatment delivery and clinical outcomes.
Area of Science:
- Neuro-oncology
- Molecular neuroscience
- Cancer therapy
Background:
- Brain tumors exhibit specific molecular lesions and signaling pathway disruptions.
- These characteristics make them suitable candidates for targeted therapy.
- The blood-brain barrier (BBB) impedes drug delivery, limiting therapeutic efficacy.
Purpose of the Study:
- To review advanced targeted therapy strategies for brain tumors.
- To present current clinical results of these targeted treatments.
- To discuss the impact of the blood-brain barrier on targeted therapy.
Main Methods:
- Literature review of advanced targeted therapy modalities.
- Analysis of clinical trial data for targeted brain tumor treatments.
- Discussion of molecular targets and signaling pathways in brain tumors.
Main Results:
- Several advanced targeted therapies are under investigation for brain tumors.
- Clinical outcomes vary depending on the specific therapy and tumor type.
- The blood-brain barrier remains a significant obstacle in delivering targeted agents.
Conclusions:
- Targeted therapy holds potential for brain tumor treatment.
- Overcoming the blood-brain barrier is crucial for therapeutic success.
- Further research is needed to optimize targeted drug delivery and efficacy.
Related Concept Videos
00:49The Blood-brain Barrier
Overview
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:23Factors Affecting Drug Distribution: Physiological Barriers
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...